CanSino Biologics Inc.

HKEX:6185.HK

30.95 (HKD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016
Assets:
Current Assets:
Cash & Cash Equivalents 2,046.9983,394.8245,456.8734,447.029202.4557.38118.24752.548
Short Term Investments 2,072.9672,551.9672,326.033666.64552.343140402.63694
Cash and Short Term Investments 4,119.9655,946.7917,782.9065,113.669754.793197.381420.883146.548
Net Receivables 636.882855.49157.92622.14317.899-135.547-266.770
Inventory 350.656677.777875.621170.51216.3388.4941.6240
Other Current Assets 1,369.5032,732.1842,336.066780.9595.215150.676271.1810.257
Total Current Assets 5,180.8287,730.1859,289.8445,420.643794.245221.004426.918146.805
Non-Current Assets:
Property, Plant & Equipment, Net 3,040.3483,083.1442,218.305881.914589.694507.449396.894158.179
Goodwill 00000000
Intangible Assets 205.647258.739198.30572.29757.21551.25640.76419.756
Goodwill and Intangible Assets 205.647258.739198.30572.29757.21551.25640.76419.756
Long Term Investments 446.556-2,501.852-2,280.723-401.199-245.475000
Tax Assets 207.861196.4100243.494000
Other Non-Current Assets 237.5292,702.3342,448.456774.418345.32516.1661.7881.433
Total Non-Current Assets 4,137.9413,738.7752,584.3431,327.43990.253574.871439.446179.368
Total Assets 9,318.76911,468.9611,874.1876,748.0731,784.498795.875866.364326.173
Liabilities & Equity:
Current Liabilities:
Account Payables 103.97253.12842.56760.5736.1716.6511.8790.734
Short Term Debt 1,459.4981,624.3351,111.96948.74729.0410.2390.170
Tax Payables 023.71934.5351.1590.490.2330.4380.063
Deferred Revenue -38.4020000000
Other Current Liabilities 1,066.7781,064.61920.406303.53389.08399.795110.87826.622
Total Current Liabilities 2,591.8442,942.0652,874.942412.853124.295106.685112.92727.356
Non-Current Liabilities:
Long Term Debt 1,240.8431,076.295262.84993.79137.758150108.33369.329
Deferred Revenue Non-Current 190.175204.998187.955170.57651.92936.87337.77215.015
Deferred Tax Liabilities Non-Current -216.718878.0080.55790130-36.873-37.772-15.015
Other Non-Current Liabilities 225.21-878.0080-90-13036.87337.77215.015
Total Non-Current Liabilities 1,439.511,281.293451.361264.366189.687186.873146.10584.344
Total Liabilities 4,031.3544,223.3583,326.303677.219313.982293.558259.032111.7
Equity:
Preferred Stock 118.3890000000
Common Stock 247.45247.45247.45247.45222.65160.951156.4440
Retained Earnings -1,558.414-75.6821,031.309-764.692-368.054-211.288-73.007-136.085
Accumulated Other Comprehensive Income/Loss -0.1760.12100-0-36.074-25.742-17.668
Other Total Stockholders Equity 6,467.3556,576.2016,716.2876,588.0961,615.92588.728549.637368.226
Total Shareholders Equity 5,274.6046,748.097,995.0466,070.8541,470.516502.317607.332214.473
Total Equity 5,287.4157,245.6028,547.8846,070.8541,470.516502.317607.332214.473
Total Liabilities & Shareholders Equity 9,318.76911,468.9611,874.1876,748.0731,784.498795.875866.364326.173